News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Cavanaugh Sarah
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Exercised 5,018 shares
@ $9.0165, valued at
$45.2k
Sold 4,302 shares
@ $44.113, valued at
$189.8k
Sold 901 shares
@ $43.061, valued at
$38.8k
Sold 2,120 shares
@ $41.619, valued at
$88.2k
Exercised 5,018 options to buy
@ $0
Exercised 938 options to buy
@ $2.78, valued at
$2.6k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2020 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 84,000 options to buy
@ $10.38, valued at
$871.9k
|
|
| 06/11/2020 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Bought 1,050 shares
@ $4.83, valued at
$5.1k
|
|
| 06/20/2019 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 43,000 options to buy
@ $2.78, valued at
$119.5k
|
|
| 06/15/2018 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 275,000 options to buy
@ $0.6011, valued at
$165.3k
|
|
| 06/16/2017 |
4
| Cavanaugh Sarah (SVP of Corp Affairs & Admin.) has filed a Form 4 on Celldex Therapeutics, Inc.|
Txns:
| Granted 65,000 options to buy
@ $2.32, valued at
$150.8k
|
|
| 06/16/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|